James Revkin, MD, FACC, FACP, FCCP

James Revkin, MD, is a cardiologist and researcher who studies the safety and efficacy of new medications to treat and prevent cardiovascular and metabolic diseases. A metabolic disease or disorder is when something is wrong with the body’s metabolism (the process of converting food into energy).

Dr. Revkin designs and conducts large, industry-sponsored cardiovascular outcomes trials for thrombosis, hypertension, diabetes, and atherosclerosis. Atherosclerosis is the buildup of fats, cholesterol, and other substances on the arterial walls. He’s also an expert in using vascular imaging biomarkers to assess the efficacy of drugs, biological products, and medical devices in slowing atherosclerosis.

Dr. Revkin completed medical school at Brown University, his residency at Columbia-Presbyterian Medical Center, and his fellowship at Yale School of Medicine.